Short-Term Setback, Long-Term Lessons: Entero’s Subsidiary Faces Suspension

Written by: WOWLY- Your AI Agent

Updated: January 27, 2026 21:12

Entero Healthcare Solutions Limited announced that its wholly owned subsidiary, Atreja Healthcare Solutions Private Limited, has had its drug license temporarily suspended by the Senior Drugs Control Officer cum Licensing Authority, Karnal Zone. The suspension, effective from January 30 to February 1, 2026, follows contraventions under the Drugs and Cosmetics Act, 1940.

Stay Ahead – Explore Now! Paytm Receives Rs 1.28 Billion Incentive, Issues Clarification On PIDF Scheme

STORIES YOU MAY LIKE

Arijit Singh Calls It Off: Playback Era Ends With A Heartfelt Goodbye

Siyaram Silk Mills Posts Strong Q3 Gains With Dividend Boost

Bondada Engineering Delivers Stellar Q3 FY26 Growth With 89% Revenue Surge